Case Study 3 - Transitioning a Patient from Twice Daily to Long-Acting GLP-1 Therapy

Presented by Davida F. Kruger, MSN, APN-BC, BC-ADM and Heather Remtema, MPH, RD, CCRP

From the series -  - Evaluating Clinical Use of Long-Acting GLP-1 Therapy in Type 2 Diabetes Treatment Regimens

Begin Presentation

To view audio/video presentations, you will need the latest version of Adobe Flash.